A real-world, observational, multi-centre study comparing budesonide MMX with prednisolone in patients with mild to moderate ulcerative colitis

被引：0
|
作者：
Kearns, Jacqueline [1 ]
Scullion, Louise [1 ]
Masterson, Caroline [2 ]
Kennedy, Noreen [2 ]
Butcher, Catherine [3 ]
机构：
[1] Northern Hlth & Social Care Trust, Antrim Area Hosp, Coleraine, Antrim, North Ireland
[2] Belfast Hlth & Social Care Trust, Royal Victoria Hosp, Ctr Ambulatory Care, Belfast, Antrim, North Ireland
[3] Northern Hlth & Social Care Trust, Causeway Hosp, Coleraine, Londonderry, North Ireland
来源：
GUT | 2023年 / 72卷 / SUPPL_2期
关键词：
D O I：
10.1136/gutjnl-2023-BSG.158
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P86
引用
收藏
页码：A97 / A98
页数：2
相关论文
共 50 条
  • [31] The influence of different prednisolone tapering algorithms on the effectiveness of infliximab in patients with Ulcerative Colitis - A real-world cohort study
    Ovesen, P. D.
    Ilvemark, J. F. K. F.
    Attauabi, M.
    Seidelin, J. B.
    [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I006 - I007
  • [32] Fecal microbiota transplantation in patients with mild to moderate ulcerative colitis is associated with early clinical response in a real-world setting
    Virmani, Shubi
    Kante, Bhaskar
    Vuyyuru, Sudheer
    Kumar, Peeyush
    Singh, Mukesh
    Makharia, Govind
    Kedia, Saurabh
    Ahuja, Vineet
    [J]. GUT, 2023, 72 (SUPPL_1) : A208 - A208
  • [33] Efficacy and safety of tofacitinib in patients with moderate-to-severe ulcerative colitis: A real-world retrospective study
    Yoshimura, N.
    Okano, Soh
    Sako, Minako
    Takazoe, Masakazu
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S545 - S545
  • [34] Evaluating induction and maintenance treatment with MMX mesalazine for patients with mild-to-moderate ulcerative colitis
    Solomon, D.
    Abhyankar, B.
    Barrett, K.
    Karlstadt, R.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 : A90 - A90
  • [35] A SINGLE-CENTRE, REAL-WORLD EXPERIENCE OF TREATING ULCERATIVE COLITIS PATIENTS WITH VEDOLIZUMAB
    Lenti, M. V.
    Cococcia, S.
    Giuffrida, P.
    Aronico, N.
    Soriano, S.
    Corazza, G. R.
    Di Sabatino, A.
    [J]. DIGESTIVE AND LIVER DISEASE, 2018, 50 (02) : E202 - E203
  • [36] Budesonide MMX® 9 mg for Inducing Remission in Patients with Mild-to-Moderate Ulcerative Colitis Not Adequately Controlled with Oral 5-ASAs
    Rubin, D. T.
    Cohen, R. D.
    Sandborn, W. J.
    Lichtenstein, G. R.
    Axler, J.
    Riddell, R.
    Zhu, C.
    Barrett, A. C.
    Bortey, E.
    Forbes, W. P.
    [J]. JOURNAL OF CROHNS & COLITIS, 2015, 9 : S7 - S7
  • [37] The effect of prolonged therapy with MMX™ mesalamine in patients with acute, mild-to-moderate ulcerative colitis
    Lichtenstein, Gary R.
    Kamm, Michael A.
    Panaccione, Remo
    Barrett, Karen
    Lees, Kirstin
    Joseph, Raymond E.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S463 - S463
  • [38] Safety and effectiveness of adalimumab treatment in 1523 patients with ulcerative colitis: Results from a prospective, multi-centre, observational study
    Ogata, H.
    Hagiwara, T.
    Ito, Y.
    Kawaberi, T.
    Kobayashi, M.
    Hibi, T.
    [J]. JOURNAL OF CROHNS & COLITIS, 2019, 13 : S414 - S415
  • [39] Real-world experience with MMX mesalazine use in Mexican patients with ulcerative colitis at two tertiary care centers
    Yamamoto-Furusho, J. K.
    Parra-Holguin, N. N.
    [J]. REVISTA DE GASTROENTEROLOGIA DE MEXICO, 2022, 87 (03): : 305 - 311
  • [40] Effectiveness and Safety of Ustekinumab for Ulcerative Colitis: A Brazilian Multicentre Real-World Observational Study
    Parra, R.
    Chebli, J. M. F.
    de Azevedo, M. Freitas Cardoso
    Chebli, L. A.
    Zabot, G. P.
    Cassol, O. S.
    Froes, R. D. S. B.
    Santana, G. O.
    Lubini, M.
    Magro, D. O.
    Imbrizi, M.
    Moraes, A. C. S.
    Teixeira, F. V.
    Alves, A. J. T., Jr.
    Gasparetti Junior, N. L. T.
    Ferreira, S. D. C.
    Queiroz, N. S. F.
    Kotze, P. G.
    Feres, O.
    [J]. JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1311 - I1311
12345